Consistent with the previous study, urine NGAL alone as well as other urinary biomarkers presented low discrimination power (0.6–0.7) for diagnosing AKI in patients with sepsis, thereby limiting its standalone utility. The gene discussed is LCN2; the disease is acute kidney injury.